Four HIV vaccines are expected to enter phase I clinical trials by the end of this year

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1245, 2000-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer vaccines entering Phase III clinical trials

By Durrant LG Spendlove I

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Ethical Issues in Phase I Cancer Clinical Trials

By Peppercorn Jeffrey

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 233-242

Adis International

Access to resources Recommend Favorite

An update on bronchodilators in Phase I and II clinical trials

By Cazzola Mario Rogliani Paola Segreti Andrea Matera Maria Gabriella

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1489-1501

Informa Healthcare

Access to resources Recommend Favorite

The ABC of HIV Clinical Trials

By Hill Andrew

Pharmaceutical Medicine, Vol. 23, Iss. 4, 2009-08 ,pp. : 201-211

Adis International

Access to resources Recommend Favorite

Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 85-102

Bentham Science Publishers

Access to resources Recommend Favorite